New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States

Oct.11.2022
New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States
The latest study on youth vaping in the US shows little progress in preventing teens from using e-cigarettes.

A new study conducted by the US government on the use of e-cigarettes among youth has shown little progress in keeping teenagers away from vaping. The survey, which was released on Thursday, suggests that more high school students are using e-cigarettes, with 14% of them reporting recent use compared to 11% in the previous year.


However, experts warn that changes in the survey make comparisons difficult: this year, there is a much higher proportion of participants surveyed in schools, and there are often more reports of e-cigarette use in schools than at home. "Assessing trends (in e-cigarette use) since the outbreak of the pandemic remains difficult," said Alyssa Harlow, a researcher at the University of Southern California who studies adolescent e-cigarette use.


Although there are still many young people using e-cigarettes, they don't seem to be as popular as before. In 2019, 28% of high school students reported having recently used e-cigarettes. For educators, e-cigarettes remain a major issue.


Interestingly, the 2021-22 academic year is worse than pre-pandemic times, according to Mike Rinaldi, the principal of Westhill High School in Connecticut. He notes that it is the first year for many students returning from remote learning during the pandemic and speculates that some may have turned to e-cigarettes to cope with pandemic-related mental health issues or stress. Matt Forker, principal of Stamford High School, says that kids vaping in school bathrooms and stairwells remains a "persistent challenge".


Researchers from the Centers for Disease Control and Prevention authored a new study based on an online survey conducted from January 18th to May 31st of approximately 28,000 American high school students. The study inquired about the use of electronic cigarettes and other vaping devices in the past 30 days. In addition to 14% of high schoolers reporting recent use of e-cigarettes, around 3% of middle schoolers reported having tried them. Among those who used e-cigarettes, approximately 28% reported daily use. Nearly 85% of young people using e-cigarettes used flavored products, with Puff Bar and Vuse being the most popular brands followed by Hyde and Smok.


After months of pressure from congressional members and parents, the US Food and Drug Administration (FDA) took action against the manufacturers of Puff Bar and Hyde on Thursday. The agency sent a warning letter to Puff Bar manufacturer, EVO Brands, stating that the company had not obtained permission to sell their products in the US and that they were being illegally sold. Only a few e-cigarette companies have received FDA approval, which is only granted to products that are beneficial to the health of adult smokers.


The agency also stated that following the denial of their FDA authorization application, they have instructed Magellan Technology, the manufacturer of Hyde, to withdraw their product from the market.


The FDA has been working to regulate the extensive e-cigarette industry, which includes both established and start-up companies. Regulatory agencies have faced criticism from Congress and anti-e-cigarette advocates as they have missed multiple deadlines and have been unable to make decisions on compliance applications for millions of e-cigarette products submitted by companies.


In the past three years, federal and state laws and regulations have increased the purchasing age for tobacco and e-cigarette products, and have banned almost all small e-cigarette flavors that are popular among teenagers.


Some children may have also been scared away by the outbreak of illnesses and deaths related to e-cigarettes in 2019 - most of whom were associated with additives in black market e-liquids containing THC, a chemical that can produce a marijuana-like high when inhaled.


A leader of an advocacy organization has stated that their efforts to combat youth vaping have not been progressing well. These figures "may not reflect the larger reality of youth e-cigarette use that we hear about every day from parents, teachers, pediatricians, and prevention experts who are dealing with this urgent and ongoing youth public health crisis," said the organization, which is made up of parents opposed to vaping, in a statement.


Earlier this summer, the U.S. Food and Drug Administration (FDA) attempted to ban products from leading e-cigarette manufacturer Juul due to concerns about potential health risks. However, after a court challenge, the effort was forced to be put on hold. In a survey conducted this year, approximately one-fifth of teenage e-cigarette users reported using Juul recently, although it is no longer the most popular brand. This is a significant shift from 2019 when over half of young people's most commonly used e-cigarette was Juul.


On the contrary, many young people have turned to electronic cigarettes that offer laboratory-manufactured nicotine, including Puff Bar, which is a loophole in the FDA supervision that was shut down by Congress this year. Despite obtaining new authorization for these products, the FDA missed the mid-July deadline to make decisions on most products.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is intended solely for industry exchange and research.


Due to limitations in translation abilities, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues and positions.


The compilation of information is subject to the ownership of the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Azerbaijan's sweeping e-cigarette ban has raised concerns over enforcement errors and the emergence of illicit sales, while neighboring Armenia is tightening technical rules and preparing higher excise taxes. Georgia, meanwhile, has resisted calls for broader vape restrictions and introduced preferential taxes for some domestically produced cigarettes. The divergent approaches across the South Caucasus highlight a regional policy dilemma: how to curb nicotine use and protect public health without encouraging black markets or creating unintended economic consequences for businesses and consumers.
Nov.03